Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BGI Genomics provides large-scale genomic and proteomic services worldwide. It has played a key role in major international projects such as the Human Genome Project and the International HapMap Project. The company’s technologies are widely used for basic research across species as well as clinical diagnostics—including COVID-19 testing—and precision medicine applications. Its proprietary BGISEQ sequencers are deployed globally. The company has developed several diagnostic kits approved by regulatory agencies in China and abroad.[1][2][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BGI Genomics.